{
    "2019-03-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Bio-Path stock soars in active trade after announcing Phase 2 trial update",
                "features": {
                    "keywords": [
                        "Bio-Path",
                        "soars",
                        "Phase 2 trial",
                        "update"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "7 Stocks That Can Outperform In a Post QE Market",
                "features": {
                    "keywords": [
                        "Outperform",
                        "Post QE",
                        "Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice",
                "features": {
                    "keywords": [
                        "High-Growth",
                        "Dividend",
                        "AbbVie",
                        "Great Choice"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "What Are Mylanâ€™s Key Growth Drivers in Fiscal 2019?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Growth Drivers",
                        "Fiscal 2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}